|
News For NVO;VPHM;INFI;MRK;AGN;SHPG;SGEN;OREX;AMGN;SNY;JNJ;PFE From The Last 14 Days Check below for free stories on NVO;VPHM;INFI;MRK;AGN;SHPG;SGEN;OREX;AMGN;SNY;JNJ;PFE the last two weeks. |
|
|
| May 8, 2013 |
| 08:32 EDT |  | MRK | Merck says FDA accepts biologics license application for allergy tablet
Merck announced that the Biologics License Application for its investigational ragweed pollen sublingual allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration. The BLA for Merck’s investigational ragweed pollen sublingual allergy immunotherapy tablet is supported by five studies evaluating the efficacy and safety of the tablet in adults, 18 years of age or older, with ragweed induced allergic rhinitis. On March 27, Merck announced that the FDA had also accepted the BLA for its investigational Timothy grass pollen sublingual allergy immunotherapy tablet. Merck expects the FDA’s review for both to be completed in the first half of 2014. |
|
| 07:38 EDT |  | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
 Subscribe for More Information |
|
| 06:09 EDT |  | AGN | Stocks with implied volatility below IV index mean; EBIX AGN
Subscribe for More Information |
|
| May 7, 2013 |
| 16:31 EDT | | AMGN | Amgen announces Phase 3 head-to-head study of Vectibix versus Erbitux
Subscribe for More Information |
|
| 16:22 EDT |  | SGEN | Seattle Genetics reports Q1 EPS (14c), consensus (20c)
Subscribe for More Information |
|
| 16:13 EDT | | INFI | Infinity Pharmaceuticals says Phase l data for IPI-145 to be presented at ASCO
Subscribe for More Information |
|
| 16:11 EDT | | INFI | Infinity Pharmaceuticals reports Q1 EPS (57c) , consensus (67c)
Subscribe for More Information |
|
| 13:08 EDT |  | AGN | Allergan can still deliver double digit earnings growth, says Argus
Subscribe for More Information |
|
| 12:32 EDT | | PFE | High option volume stocks: ALDW BC NMM PFE AEP
|
|
| 08:09 EDT | | PFE | Accelrys, Pfizer extend agremeent for global deployment of Lifecycle software
Subscribe for More Information |
| |
| 06:22 EDT |  | INFI | Infinity Pharmaceuticals initiated with a Neutral at Goldman
Subscribe for More Information |
|
| 05:57 EDT | | AGN | Stocks with implied volatility below IV index mean; IBM AGN
Subscribe for More Information |
|
| May 6, 2013 |
| 17:03 EDT | | PFE | Bristol-Myers, Pfizer announce publication of ARISTOTLE trial
Bristol-Myers Squibb (BMY) and Pfizer (PFE) announced that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from this subanalysis showed that the reductions in stroke or systemic embolism, number of major bleeding events and mortality demonstrated with Eliquis compared to warfarin in the ARISTOTLE trial were consistent across subgroups defined based on levels of International Normalized Ratio control in patients with nonvalvular atrial fibrillation. Based on the results of the subanalysis, the benefits of Eliquis compared with warfarin for stroke or systemic embolism, bleeding, and mortality appear similar across the range of centers' and patients' quality of INR control. |
|
| 11:29 EDT |  | JNJ | J&J cosmetics license revoked at Mumbai plant, Reuters says
Subscribe for More Information |
|
| 10:00 EDT | | OREX | Orexigen management to meet with JPMorgan
Subscribe for More Information |
|
| 08:53 EDT | | MRK | BofA/Merrill's major pharma analysts hold an analyst/industry conference call
Subscribe for More Information |
|
| 08:02 EDT | | PFE | Pfizer launches Viagra home delivery, powered by CVS/pharmacy
To meet the needs of consumers who are increasingly going online to purchase prescription medications, Pfizer (PFE) launched Viagra home delivery, a new prescription-fulfillment website for Viagra tablets, Pfizer’s most counterfeited medicine. The site, which is powered by CVS/pharmacy (CVS) and accessible through Viagra.com, offers men with erectile dysfunction an opportunity to purchase Viagra online with a valid prescription from a trusted source. |
|
| 07:51 EDT | | PFE | Pfizer to sell Viagra directly to patients on its website, Fox News reports
In a move that changes the drug industry's distribution model, Pfizer told The Associated Press that it will begin selling Viagra directly to patients on its website, reports Fox News. Men still will need a prescription to buy it, and Pfizer is offering three free pills with the first order and 30% off the second one. Reference Link |
|
| 07:49 EDT | | SNY | Bernstein's global pharmaceuticals analyst has analyst/industry conference call
Subscribe for More Information |
|
| 07:34 EDT | | PFE | Conference Forum to host a summit
Subscribe for More Information |
| |
|
|
|
|
